Medicine and Dentistry
Rapamycin
89%
Percutaneous Coronary Intervention
69%
Optical Coherence Tomography
54%
ST Segment Elevation Myocardial Infarction
50%
Intravascular Ultrasound
46%
Coronary Microvascular Dysfunction
45%
Angina pectoris
44%
Coronary Artery Disease
44%
Everolimus
42%
Coronary Flow Reserve
36%
Myocardial Infarction
35%
Umirolimus
29%
Primary Percutaneous Coronary Intervention
29%
Acute Heart Infarction
28%
Target Lesion
27%
Angina Pectoris
26%
Drug-Eluting Stent
26%
Non ST Segment Elevation Myocardial Infarction
25%
CD34 Antibody
24%
Coronary Artery
23%
Target Lesion Revascularization
21%
Diabetes Mellitus
21%
Heart Death
21%
Revascularization
21%
Infarction
20%
Diabetes
20%
Acute Coronary Syndrome
19%
Hazard Ratio
19%
Stent Thrombosis
18%
Heart Muscle Ischemia
17%
Coronary Artery Obstruction
16%
Doppler Echocardiography
15%
Angiography
15%
Cardiac Magnetic Resonance Imaging
14%
Ischemia
14%
Reperfusion Injury
12%
Major Adverse Cardiac Event
12%
Paclitaxel
12%
C Reactive Protein
12%
Lung
12%
Stable Angina Pectoris
11%
Heart Left Ventricle Ejection Fraction
11%
Coronary Angiography
10%
Noninferiority Trial
9%
Stenosis
9%
Intention-to-Treat Analysis
9%
Magnesium
9%
Vasospasm
9%
Randomized Clinical Trial
9%
Arm
8%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
ST Segment Elevation Myocardial Infarction
62%
Umirolimus
48%
Heart Infarction
41%
Coronary Artery Disease
37%
Everolimus
36%
Heart Death
31%
Acute Heart Infarction
30%
CD34 Antibody
30%
Infarction
25%
Acute Coronary Syndrome
24%
Stent Thrombosis
23%
Angina Pectoris
21%
Heart Muscle Ischemia
19%
Major Adverse Cardiac Event
15%
Randomized Clinical Trial
14%
Statin (Protein)
12%
Reperfusion Injury
12%
Stenosis
12%
Dipyridamole
12%
Ischemia
12%
Rosuvastatin
12%
Ezetimibe
12%
Placebo
11%
Noninferiority Trial
11%
Stable Angina Pectoris
10%
Stainless Steel
10%
Heart Muscle Injury
9%
C Reactive Protein
8%
Diabetes Mellitus
8%
Atorvastatin
7%
Cardiovascular Risk
7%
Placebo-Controlled Study
6%
Low Density Lipoprotein Cholesterol
6%
Ischemic Heart Disease
6%
Respiratory Tract Allergy
6%
Lipoprotein
6%
Melatonin
6%
Left Ventricular Diastolic Dysfunction
6%
Interleukin 6
6%
Acetylcysteine
6%
Prospective Cohort Study
6%
Contrast Induced Nephropathy
6%
Zotarolimus
6%
Dicarbonate
6%
Polyethylene Terephthalate
6%
Coronary Artery Spasm
6%
Cardiovascular Disease
6%
Pentraxin 3
6%
Muscle Spasm
6%
Nursing and Health Professions
Clinical Outcome
18%
Stent
18%
Coronary Artery Disease
15%
Drug Eluting Coronary Stent
15%
Rapamycin
12%
Revascularization
12%
Cardiovascular Risk
9%
ST Segment Elevation Myocardial Infarction
8%
Doppler Echocardiography
7%
Diabetes Mellitus
7%
Angina Pectoris
7%
Percutaneous Coronary Intervention
6%
Intravascular Ultrasound
6%
Patient Coding
6%
Left Ventricular Diastolic Dysfunction
6%
Acute Heart Infarction
6%
Infarction
6%
Asthma
6%
Perfusion
6%
Patient with Type 2 Diabetes
6%
Heart Ejection Fraction
6%
Heart Muscle Perfusion
6%
Acute Coronary Syndrome
6%
Catheter
6%
Reproducibility
6%
Morphometry
6%
Optical Coherence Tomography
6%
Non Insulin Dependent Diabetes Mellitus
6%
Heart Death
5%
